INNOVIVA, INC. Operating Cash Flow
INNOVIVA, INC. (INVA) reported Operating Cash Flow of $87.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- INNOVIVA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $51.97M, a 17.92% increase year-over-year.
- INNOVIVA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $35.28M, a 27.43% decline year-over-year.
- INNOVIVA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $54.51M, a 7.98% decline year-over-year.
- INNOVIVA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $49.73M, a 2.14% increase year-over-year.
- INNOVIVA, INC. net cash provided by (used in) operating activities for fiscal 2025 was $196.93M, a 4.37% increase from fiscal 2024.
- INNOVIVA, INC. net cash provided by (used in) operating activities for fiscal 2024 was $188.69M, a 33.76% increase from fiscal 2023.
- INNOVIVA, INC. net cash provided by (used in) operating activities for fiscal 2023 was $141.06M, a 30.07% decline from fiscal 2022.
- INNOVIVA, INC. net cash provided by (used in) operating activities for fiscal 2022 was $201.73M, a 44.55% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $51.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $87.25M 10-Q · filed 2026-08-05 | $141.77M derived: sum of 3 quarters · filed 2026-08-05 | $191.49M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $35.28M 10-Q · filed 2026-05-06 | $89.80M derived: sum of 2 quarters · filed 2026-05-06 | $139.52M derived: sum of 3 quarters · filed 2026-05-06 | $183.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $54.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $104.24M derived: sum of 2 quarters · filed 2026-02-25 | $148.31M derived: sum of 3 quarters · filed 2026-08-05 | $196.93M 10-K · filed 2026-02-25 |
| 2025-09-30 | $49.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $93.80M derived: sum of 2 quarters · filed 2026-08-05 | $142.42M 10-Q · filed 2025-11-05 | $201.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $44.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $92.69M 10-Q · filed 2026-08-05 | $151.93M derived: sum of 3 quarters · filed 2026-08-05 | $200.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $48.62M 10-Q · filed 2026-05-06 | $107.86M derived: sum of 2 quarters · filed 2026-05-06 | $156.54M derived: sum of 3 quarters · filed 2026-05-06 | $200.26M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $59.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $107.92M derived: sum of 2 quarters · filed 2026-02-25 | $151.64M derived: sum of 3 quarters · filed 2026-02-25 | $188.69M 10-K · filed 2026-02-25 |
| 2024-09-30 | $48.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $92.40M derived: sum of 2 quarters · filed 2025-11-05 | $129.45M 10-Q · filed 2025-11-05 | $162.71M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $43.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $80.77M 10-Q · filed 2025-08-06 | $114.02M derived: sum of 3 quarters · filed 2026-02-25 | $157.96M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $37.05M 10-Q · filed 2025-05-07 | $70.30M derived: sum of 2 quarters · filed 2026-02-25 | $114.25M derived: sum of 3 quarters · filed 2026-02-25 | $152.43M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $33.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $77.20M derived: sum of 2 quarters · filed 2026-02-25 | $115.38M derived: sum of 3 quarters · filed 2026-02-25 | $141.06M 10-K · filed 2026-02-25 |
| 2023-09-30 | $43.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $82.12M derived: sum of 2 quarters · filed 2024-11-06 | $107.81M 10-Q · filed 2024-11-06 | $116.71M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $38.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $63.87M 10-Q · filed 2024-07-31 | $72.77M derived: sum of 3 quarters · filed 2025-02-26 | $88.45M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $25.68M 10-Q · filed 2024-05-08 | $34.58M derived: sum of 2 quarters · filed 2025-02-26 | $50.27M derived: sum of 3 quarters · filed 2025-02-26 | $129.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $24.59M derived: sum of 2 quarters · filed 2025-02-26 | $103.62M derived: sum of 3 quarters · filed 2025-02-26 | $201.73M 10-K · filed 2025-02-26 |
| 2022-09-30 | $15.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $94.72M derived: sum of 2 quarters · filed 2023-11-01 | $192.83M 10-Q · filed 2023-11-01 | $291.21M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $79.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $177.14M 10-Q · filed 2023-08-02 | $275.52M derived: sum of 3 quarters · filed 2024-03-05 | $372.23M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $98.10M 10-Q · filed 2023-05-09 | $196.48M derived: sum of 2 quarters · filed 2024-03-05 | $293.19M derived: sum of 3 quarters · filed 2024-03-05 | $377.81M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $98.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $195.09M derived: sum of 2 quarters · filed 2024-03-05 | $279.71M derived: sum of 3 quarters · filed 2024-03-05 | $363.81M 10-K/A · filed 2024-03-05 |
| 2021-09-30 | $96.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $181.32M derived: sum of 2 quarters · filed 2022-11-09 | $265.43M 10-Q · filed 2022-11-09 | $350.71M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $84.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $168.72M 10-Q · filed 2022-07-27 | $254.00M derived: sum of 3 quarters · filed 2023-02-28 | $328.56M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $84.11M 10-Q · filed 2022-05-05 | $169.39M derived: sum of 2 quarters · filed 2023-02-28 | $243.94M derived: sum of 3 quarters · filed 2023-02-28 | $323.74M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $85.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $159.84M derived: sum of 2 quarters · filed 2023-02-28 | $239.63M derived: sum of 3 quarters · filed 2023-02-28 | $313.11M 10-K · filed 2023-02-28 |
| 2020-09-30 | $74.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $154.35M derived: sum of 2 quarters · filed 2021-10-27 | $227.83M 10-Q · filed 2021-10-27 | $294.74M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | $79.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $153.28M 10-Q · filed 2021-07-29 | $220.18M derived: sum of 3 quarters · filed 2022-03-17 | $277.58M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | $73.48M 10-Q · filed 2021-04-28 | $140.39M derived: sum of 2 quarters · filed 2022-03-17 | $197.79M derived: sum of 3 quarters · filed 2022-03-17 | $254.28M derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | $66.91M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $124.31M derived: sum of 2 quarters · filed 2022-03-17 | $180.80M derived: sum of 3 quarters · filed 2022-03-17 | $257.46M 10-K/A · filed 2022-03-17 |
| 2019-09-30 | $57.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $113.90M derived: sum of 2 quarters · filed 2020-10-28 | $190.55M 10-Q · filed 2020-10-28 | $252.33M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $56.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $133.15M 10-Q · filed 2020-07-29 | $194.93M derived: sum of 3 quarters · filed 2021-02-25 | $255.04M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $76.66M 10-Q · filed 2020-04-29 | $138.43M derived: sum of 2 quarters · filed 2021-02-25 | $198.55M derived: sum of 3 quarters · filed 2021-02-25 | $250.27M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $61.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $121.89M derived: sum of 2 quarters · filed 2021-02-25 | $173.62M derived: sum of 3 quarters · filed 2021-02-25 | $223.53M 10-K · filed 2021-02-25 |
| 2018-09-30 | $60.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $111.84M derived: sum of 2 quarters · filed 2019-10-30 | $161.75M 10-Q · filed 2019-10-30 | $209.61M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $51.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $101.64M 10-Q · filed 2019-07-24 | $149.50M derived: sum of 3 quarters · filed 2020-02-19 | $192.99M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $49.91M 10-Q · filed 2019-05-01 | $97.77M derived: sum of 2 quarters · filed 2020-02-19 | $141.26M derived: sum of 3 quarters · filed 2020-02-19 | $163.90M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $47.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $91.35M derived: sum of 2 quarters · filed 2020-02-19 | $113.99M derived: sum of 3 quarters · filed 2020-02-19 | $141.75M 10-K · filed 2020-02-19 |
| 2017-09-30 | $43.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $66.13M derived: sum of 2 quarters · filed 2018-10-31 | $93.89M 10-Q · filed 2018-10-31 | $114.98M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $22.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $50.40M 10-Q · filed 2018-07-26 | $71.49M derived: sum of 3 quarters · filed 2019-02-19 | $91.67M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $27.76M 10-Q · filed 2018-05-04 | $48.85M derived: sum of 2 quarters · filed 2019-02-19 | $69.03M derived: sum of 3 quarters · filed 2019-02-19 | $81.50M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $21.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $41.27M derived: sum of 2 quarters · filed 2019-02-19 | $53.73M derived: sum of 3 quarters · filed 2019-02-19 | $60.98M 10-K · filed 2019-02-19 |
| 2016-09-30 | $20.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $32.65M derived: sum of 2 quarters · filed 2017-11-03 | $39.90M 10-Q · filed 2017-11-03 | $46.81M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $12.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $19.71M 10-Q · filed 2017-08-08 | $26.63M derived: sum of 3 quarters · filed 2018-02-23 | $29.28M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $7.25M 10-Q · filed 2016-05-05 | $14.17M derived: sum of 2 quarters · filed 2018-02-23 | $16.82M derived: sum of 3 quarters · filed 2018-02-23 | $19.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $9.57M derived: sum of 2 quarters · filed 2018-02-23 | $11.75M derived: sum of 3 quarters · filed 2018-02-23 | $10.13M 10-K · filed 2018-02-23 |
| 2015-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.83M derived: sum of 2 quarters · filed 2016-11-03 | $3.21M 10-Q · filed 2016-11-03 | -$1.40M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $558.00K 10-Q · filed 2016-08-04 | -$4.05M derived: sum of 3 quarters · filed 2017-02-28 | -$25.12M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$1.62M 10-Q · filed 2016-05-05 | -$6.23M derived: sum of 2 quarters · filed 2017-02-28 | -$27.30M derived: sum of 3 quarters · filed 2017-02-28 | -$81.70M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$25.68M derived: sum of 2 quarters · filed 2017-02-28 | -$80.09M derived: sum of 3 quarters · filed 2017-02-28 | -$130.72M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$21.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$75.48M derived: sum of 2 quarters · filed 2015-11-05 | -$126.11M 10-Q · filed 2015-11-05 | -$166.09M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | -$54.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$105.04M 10-Q · filed 2015-08-06 | -$145.02M derived: sum of 3 quarters · filed 2016-02-24 | -$186.33M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | -$50.64M 10-Q · filed 2015-05-08 | -$90.61M derived: sum of 2 quarters · filed 2016-02-24 | -$131.92M derived: sum of 3 quarters · filed 2016-02-24 | |
| 2013-12-31 | -$39.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$81.28M derived: sum of 2 quarters · filed 2016-02-24 | -$129.60M 10-K · filed 2016-02-24 | |
| 2013-09-30 | -$41.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$89.63M 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | -$48.32M 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | -$127.51M 10-K · filed 2015-02-27 | |||
| 2011-06-30 | -$43.65M 10-Q · filed 2011-08-03 | |||
| 2010-06-30 | -$40.89M 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |